U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Carcinoma

MedGen UID:
2867
Concept ID:
C0007097
Neoplastic Process
Synonyms: Carcinomas; Epithelial Neoplasm, Malignant; Epithelial Neoplasms, Malignant; Epithelial Tumor, Malignant; Epithelial Tumors, Malignant; Epithelioma; Epitheliomas; Malignant Epithelial Neoplasm; Malignant Epithelial Neoplasms; Malignant Epithelial Tumor; Malignant Epithelial Tumors; Neoplasm, Malignant Epithelial; Neoplasms, Malignant Epithelial; Tumor, Malignant Epithelial
SNOMED CT: Carcinoma (722688002); Malignant epithelial neoplasm (722688002); Malignant epithelial neoplasm (1187225007); Carcinoma (1187425009); Malignant epithelial tumor (1187425009)
 
HPO: HP:0030731
Monarch Initiative: MONDO:0004993

Definition

A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas (NCI Thesaurus). [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVCarcinoma

Conditions with this feature

Aicardi syndrome
MedGen UID:
61236
Concept ID:
C0175713
Disease or Syndrome
Aicardi syndrome is a neurodevelopmental disorder that affects primarily females. Initially it was characterized by a typical triad of agenesis of the corpus callosum, central chorioretinal lacunae, and infantile spasms. As more affected individuals have been ascertained, it has become clear that not all affected girls have all three features of the classic triad and that other neurologic and systemic defects are common, including other brain malformations, optic nerve abnormalities, other seizure types, intellectual disability of varying severity, and scoliosis.
Dyskeratosis congenita, X-linked
MedGen UID:
216941
Concept ID:
C1148551
Disease or Syndrome
Dyskeratosis congenita and related telomere biology disorders (DC/TBD) are caused by impaired telomere maintenance resulting in short or very short telomeres. The phenotypic spectrum of telomere biology disorders is broad and includes individuals with classic dyskeratosis congenita (DC) as well as those with very short telomeres and an isolated physical finding. Classic DC is characterized by a triad of dysplastic nails, lacy reticular pigmentation of the upper chest and/or neck, and oral leukoplakia, although this may not be present in all individuals. People with DC/TBD are at increased risk for progressive bone marrow failure (BMF), myelodysplastic syndrome or acute myelogenous leukemia, solid tumors (usually squamous cell carcinoma of the head/neck or anogenital cancer), and pulmonary fibrosis. Other findings can include eye abnormalities (epiphora, blepharitis, sparse eyelashes, ectropion, entropion, trichiasis), taurodontism, liver disease, gastrointestinal telangiectasias, and avascular necrosis of the hips or shoulders. Although most persons with DC/TBD have normal psychomotor development and normal neurologic function, significant developmental delay is present in both forms; additional findings include cerebellar hypoplasia (Hoyeraal Hreidarsson syndrome) and bilateral exudative retinopathy and intracranial calcifications (Revesz syndrome and Coats plus syndrome). Onset and progression of manifestations of DC/TBD vary: at the mild end of the spectrum are those who have only minimal physical findings with normal bone marrow function, and at the severe end are those who have the diagnostic triad and early-onset BMF.
PTEN hamartoma tumor syndrome with granular cell tumor
MedGen UID:
400984
Concept ID:
C1866376
Neoplastic Process
Multiple endocrine neoplasia type 4
MedGen UID:
373469
Concept ID:
C1970712
Neoplastic Process
Multiple endocrine neoplasia type 4 (MEN4) is characterized by the development of endocrine tumors, especially those involving the parathyroid and/or pituitary gland. Parathyroid adenomas and parathyroid hyperplasia manifest as hypercalcemia (primary hyperparathyroidism) as a result of the overproduction of parathyroid hormone. Anterior pituitary adenomas can secrete adrenocorticotrophic hormone (ACTH), growth hormone (GH), prolactin, or are nonfunctional (nonsecreting) adenomas. Well-differentiated endocrine tumors of the gastroenteropancreatic tract, carcinoid tumors, and adrenocortical tumors can also occur.
Familial adenomatous polyposis 1
MedGen UID:
398651
Concept ID:
C2713442
Disease or Syndrome
APC-associated polyposis conditions include (classic or attenuated) familial adenomatous polyposis (FAP) and gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS). FAP is a colorectal cancer (CRC) predisposition syndrome that can manifest in either classic or attenuated form. Classic FAP is characterized by hundreds to thousands of adenomatous colonic polyps, beginning on average at age 16 years (range 7-36 years). For those with the classic form of FAP, 95% of individuals have polyps by age 35 years; CRC is inevitable without colectomy. The mean age of CRC diagnosis in untreated individuals is 39 years (range 34-43 years). The attenuated form is characterized by multiple colonic polyps (average of 30), more proximally located polyps, and a diagnosis of CRC at a later age than in classic FAP. For those with an attenuated form, there is a 70% lifetime risk of CRC and the mean age of diagnosis is 50-55 years. Extracolonic manifestations are variably present and include polyps of the stomach and duodenum, osteomas, dental abnormalities, congenital hypertrophy of the retinal pigment epithelium (CHRPE), benign cutaneous lesions, desmoid tumors, adrenal masses, and other associated cancers. GAPPS is characterized by proximal gastric polyposis, increased risk of gastric adenocarcinoma, and no duodenal or colonic involvement in most individuals reported.
Palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome
MedGen UID:
461281
Concept ID:
C3149931
Disease or Syndrome
Palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome is characterised by sex reversal in males with a 46, XX (SRY-negative) karyotype, palmoplantar hyperkeratosis and a predisposition to squamous cell carcinoma. To date, five cases (four of whom were brothers) have been described. The aetiology is unknown.
Colorectal cancer, susceptibility to, 12
MedGen UID:
767374
Concept ID:
C3554460
Finding
Colorectal cancer-12 (CRCS12) is an autosomal dominant disorder characterized by a high-penetrance predisposition to the development of colorectal adenomas and carcinomas, with a variable tendency to develop multiple and large tumors. Onset usually occurs before age 40 years. The histologic features of the tumors may be unremarkable (Palles et al., 2013) or show microsatellite instability (MSI) (Elsayed et al., 2015). For a general phenotypic description and a discussion of genetic heterogeneity of colorectal cancer, see 114500.
Corneal intraepithelial dyskeratosis-palmoplantar hyperkeratosis-laryngeal dyskeratosis syndrome
MedGen UID:
815206
Concept ID:
C3808876
Neoplastic Process
Multiple self-healing palmoplantar carcinoma (MSPC) is characterized by recurrent keratoacanthomas in palmoplantar skin as well as in conjunctival and corneal epithelia. In addition, patients experience a high susceptibility to malignant squamous cell carcinoma (summary by Zhong et al., 2016).

Professional guidelines

PubMed

Peris K, Fargnoli MC, Kaufmann R, Arenberger P, Bastholt L, Seguin NB, Bataille V, Brochez L, Del Marmol V, Dummer R, Forsea AM, Gaudy-Marqueste C, Harwood CA, Hauschild A, Höller C, Kandolf L, Kellerners-Smeets NWJ, Lallas A, Leiter U, Malvehy J, Marinović B, Mijuskovic Z, Moreno-Ramirez D, Nagore E, Nathan P, Stratigos AJ, Stockfleth E, Tagliaferri L, Trakatelli M, Vieira R, Zalaudek I, Garbe C; EADO”A, EDF”B, ESTRO”C, UEMS”D and EADV”E
Eur J Cancer 2023 Oct;192:113254. Epub 2023 Jul 28 doi: 10.1016/j.ejca.2023.113254. PMID: 37604067
Powles T, Bellmunt J, Comperat E, De Santis M, Huddart R, Loriot Y, Necchi A, Valderrama BP, Ravaud A, Shariat SF, Szabados B, van der Heijden MS, Gillessen S; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org
Ann Oncol 2022 Mar;33(3):244-258. Epub 2021 Nov 30 doi: 10.1016/j.annonc.2021.11.012. PMID: 34861372
Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, Stowasser M, Young WF Jr
J Clin Endocrinol Metab 2016 May;101(5):1889-916. Epub 2016 Mar 2 doi: 10.1210/jc.2015-4061. PMID: 26934393

Recent clinical studies

Etiology

J Obstet Gynaecol Res 2023 Mar;49 Suppl 1:84-86. doi: 10.1111/jog.15587. PMID: 36945814
Cantù G
Acta Otorhinolaryngol Ital 2021 Aug;41(4):296-307. doi: 10.14639/0392-100X-N1729. PMID: 34533533Free PMC Article
Tchekmedyian V
Hematol Oncol Clin North Am 2021 Oct;35(5):973-990. doi: 10.1016/j.hoc.2021.05.011. PMID: 34503735
Álvarez-Salafranca M, Ara M, Zaballos P
Actas Dermosifiliogr (Engl Ed) 2021 Apr;112(4):330-338. Epub 2020 Nov 28 doi: 10.1016/j.ad.2020.11.011. PMID: 33259816
Hong YK, McMasters KM, Egger ME, Ajkay N
Am J Surg 2018 Nov;216(5):998-1003. Epub 2018 Jun 18 doi: 10.1016/j.amjsurg.2018.06.013. PMID: 30244816

Diagnosis

Gupta S, Chopra D
J Cutan Med Surg 2024 Jan-Feb;28(1):105. Epub 2024 Jan 8 doi: 10.1177/12034754231224382. PMID: 38189245
Heath CR, Usatine RP
Cutis 2023 Aug;112(2):97-98. doi: 10.12788/cutis.0820. PMID: 37820338
Whaley RD, Gupta S, Erickson LA
Mayo Clin Proc 2023 Sep;98(9):1427-1428. doi: 10.1016/j.mayocp.2023.07.018. PMID: 37661153
Heath CR, Usatine RP
J Fam Pract 2023 Jul;72(6):E13-E15. doi: 10.12788/jfp.0644. PMID: 37549403
Ulloa-Ortiz Ó, Martínez-Fernández P, Rivera-Silva G
Med Clin (Barc) 2020 Dec 11;155(11):517. Epub 2019 Nov 20 doi: 10.1016/j.medcli.2019.09.004. PMID: 31759692

Therapy

Ashai N, Prasad P, Rajdev L
Curr Treat Options Oncol 2019 May 29;20(7):58. doi: 10.1007/s11864-019-0655-0. PMID: 31144050
Ielasi L, Tovoli F, Piscaglia F
Drugs Today (Barc) 2019 May;55(5):305-313. doi: 10.1358/dot.2019.55.5.2969817. PMID: 31131841
Tovoli F, Granito A, De Lorenzo S, Bolondi L
Drugs Today (Barc) 2018 Jan;54(1):5-13. doi: 10.1358/dot.2018.54.1.2736667. PMID: 29569657
Liu S, Lee JJ
Chin Clin Oncol 2015 Sep;4(3):33. doi: 10.3978/j.issn.2304-3865.2015.06.07. PMID: 26408300
Wörns MA, Galle PR
Nat Rev Gastroenterol Hepatol 2014 Jul;11(7):447-52. Epub 2014 Feb 4 doi: 10.1038/nrgastro.2014.10. PMID: 24492278

Prognosis

Mann H, Seligman K, Colwell N, Burr A, Glazer TA
Otolaryngol Clin North Am 2023 Apr;56(2):305-312. doi: 10.1016/j.otc.2022.11.001. PMID: 37030943
Rumgay H, Arnold M, Ferlay J, Lesi O, Cabasag CJ, Vignat J, Laversanne M, McGlynn KA, Soerjomataram I
J Hepatol 2022 Dec;77(6):1598-1606. Epub 2022 Oct 5 doi: 10.1016/j.jhep.2022.08.021. PMID: 36208844Free PMC Article
Petrelli F, Cortellini A, Indini A, Tomasello G, Ghidini M, Nigro O, Salati M, Dottorini L, Iaculli A, Varricchio A, Rampulla V, Barni S, Cabiddu M, Bossi A, Ghidini A, Zaniboni A
JAMA Netw Open 2021 Mar 1;4(3):e213520. doi: 10.1001/jamanetworkopen.2021.3520. PMID: 33779745Free PMC Article
Howlader N, Forjaz G, Mooradian MJ, Meza R, Kong CY, Cronin KA, Mariotto AB, Lowy DR, Feuer EJ
N Engl J Med 2020 Aug 13;383(7):640-649. doi: 10.1056/NEJMoa1916623. PMID: 32786189Free PMC Article
Li J, Zou B, Yeo YH, Feng Y, Xie X, Lee DH, Fujii H, Wu Y, Kam LY, Ji F, Li X, Chien N, Wei M, Ogawa E, Zhao C, Wu X, Stave CD, Henry L, Barnett S, Takahashi H, Furusyo N, Eguchi Y, Hsu YC, Lee TY, Ren W, Qin C, Jun DW, Toyoda H, Wong VW, Cheung R, Zhu Q, Nguyen MH
Lancet Gastroenterol Hepatol 2019 May;4(5):389-398. Epub 2019 Mar 20 doi: 10.1016/S2468-1253(19)30039-1. PMID: 30902670

Clinical prediction guides

Nash J, Shahwan KT, Chung C, Abidi N, Gokun Y, Pan X, Carr DR
J Am Acad Dermatol 2022 Oct;87(4):895-897. Epub 2021 Dec 15 doi: 10.1016/j.jaad.2021.12.015. PMID: 34920027
Van Bockstal MR, Berlière M, Duhoux FP, Galant C
Am J Clin Pathol 2020 Oct 13;154(5):596-609. doi: 10.1093/ajcp/aqaa077. PMID: 32566938
Takahashi Y, Fukusato T
World J Gastroenterol 2014 Nov 14;20(42):15539-48. doi: 10.3748/wjg.v20.i42.15539. PMID: 25400438Free PMC Article
Montgomery E
Arch Pathol Lab Med 2005 Feb;129(2):174-6. doi: 10.5858/2005-129-174-ITAWFP. PMID: 15679414
Sardanelli F
Eur Radiol 2004 Jun;14 Suppl 7:O65-70; discussion O84-5. doi: 10.1007/s10406-004-0066-5. PMID: 15503379

Recent systematic reviews

Patel P, Wang J, Bitterman D, Mineroff J, Austin E, Jagdeo J
Arch Dermatol Res 2024 Mar 18;316(4):108. doi: 10.1007/s00403-024-02839-y. PMID: 38498070
Feng N, Yu F, Yu F, Feng Y, Zhu X, Xie Z, Zhai Y
Medicine (Baltimore) 2022 Jan 21;101(3):e28510. doi: 10.1097/MD.0000000000028510. PMID: 35060504Free PMC Article
Reiter O, Mimouni I, Dusza S, Halpern AC, Leshem YA, Marghoob AA
J Am Acad Dermatol 2021 Sep;85(3):653-664. Epub 2019 Nov 7 doi: 10.1016/j.jaad.2019.11.008. PMID: 31706938Free PMC Article
Zaorsky NG, Lee CT, Zhang E, Keith SW, Galloway TJ
Radiother Oncol 2017 Oct;125(1):13-20. Epub 2017 Aug 23 doi: 10.1016/j.radonc.2017.08.011. PMID: 28843727Free PMC Article
Lomas A, Leonardi-Bee J, Bath-Hextall F
Br J Dermatol 2012 May;166(5):1069-80. doi: 10.1111/j.1365-2133.2012.10830.x. PMID: 22251204

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...